Aqua Bio Technology — Proxy Solicitation & Information Statement 2022

Jun 9, 2022

AQUA BIO TECHNOLOGY – DISCLOSURE OF VOTING PROXIES FOR THE ANNUAL GENERAL MEETING

9.6.2022 12:41:40 CEST | Aqua Bio Technology ASA | Major shareholding notifications

Edvard Cock has, as chairman of the Board of Directors of Aqua Bio Technology ASA ("ABT"), received proxies to vote for 4,801,230 shares at the annual general meeting on 9 June 2022 (the "AGM") without any voting instructions, representing approx. 23,2% of the total shares and votes in the company. Håvard Lindstrøm, as CEO, received proxies to vote for 1,357,566 shares, without any voting instructions, representing 6,58% of the shares and votes in the company. The proxies received are only valid for the AGM and will lapse automatically thereafter.

Further, Blixen Invest AS, a company wholly-owned by Edvard Cock, holds 1,280,793 shares in ABT, and together with the received proxies, Edvard Cock may therefore vote for 6,082,023 shares, representing approx. 29,49% of the votes in the company.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941 32 288.

* * *

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the Company's strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments

Download announcement as PDF.pdf